Essa Pharma
Our Science
  • . IND Candidate EPI-7386 as an N-terminal Domain Androgen Receptor Inhibitor in Development for the Treatment of Prostate Cancer. American Society of Clinical Oncology Genitourinary Cancers Symposium 2020. (Abstract ID #142).

    2020 Genitourinary Cancers Symposium Poster